• Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
  • Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
  • Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us

Hypothesis-Driven Weight of Evidence Evaluation Indicates Ethylbenzene Lacks Endocrine Disruption Potential by EATS Pathways

by Susan Borgert | Aug 6, 2025 | Publications

Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathways

by Susan Borgert | Aug 6, 2025 | Publications

Beyond key characteristics of carcinogens: an archetypal MOA-based evidence system for hypothesis testing to advance carcinogen risk assessment

by Susan Borgert | Aug 6, 2025 | Publications

Categorizing the characteristics of human carcinogens: a need for specificity

by Susan Borgert | Aug 6, 2025 | Publications

Avoiding a reproducibility crisis in regulatory toxicology—on the fundamental role of ring trials

by Susan Borgert | Aug 6, 2025 | Publications

« Older Entries
Next Entries »

Recent Posts

  • Webinar 2: THE KEY CHARACTERISTICS APPROACH – A Mechanistic Misfit?
  • Webinar 1: The Key Characteristics Approach – Fit For Purpose
  • Endocrine Policy Forum website created

Recent Comments

    Archives

    • March 2026
    • October 2017

    Categories

    • Issue Analysis
    • Pamphlets
    • Presentations
    • Publications
    • Spotlight Topic
    • Uncategorized
    • Videos

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    The EPF welcomes your input and questions.